- Revenues of $4.0 billion,
up 7% year-over-year
- Net income of $283
million or $2.07 per diluted
share
- Adjusted EBITDA (non-GAAP) of $490 million (12.3% margin)
- Non-GAAP Diluted Earnings per Share of
$2.29, up 56%
year-over-year
- Cash Flows from Operations of $63
million; Free Cash Flow (non-GAAP) of $46 million
- Net Bookings of $3.7
billion (book-to-bill ratio of 0.9 for the quarter and 1.1
for trailing twelve months)
RESTON,
Va., April 30, 2024 /PRNewswire/ -- Leidos
Holdings, Inc. (NYSE: LDOS), a FORTUNE 500® innovation
company, today reported financial results for the first quarter of
fiscal year 2024.
Thomas Bell, Leidos Chief
Executive Officer, commented, "Our strong start to the year
demonstrates the team's ability to deliver for its employees,
customers, and shareholders. With greater visibility around
customer funding and performance ahead of plan, we are raising
guidance on all metrics ahead of our typical pace. We fully expect
that 2024 will showcase our commitment to profitable growth. Going
forward, our focus remains on operational execution while we
develop a robust strategy, invest in disruptive technology-driven
solutions, and unlock maximum value through our capability-based
organization."
Summary Operating
Results
|
|
|
|
Three Months
Ended
|
(in millions, except
margin and per share data)
|
|
March 29,
2024
|
|
March 31,
2023
|
Revenues
|
|
$
3,975
|
|
$
3,699
|
Net income
|
|
$
283
|
|
$
164
|
Net income
margin
|
|
7.1 %
|
|
4.4 %
|
Diluted earnings per
share (EPS)
|
|
$
2.07
|
|
$
1.17
|
|
|
|
|
|
Non-GAAP
Measures*:
|
|
|
|
|
Adjusted
EBITDA
|
|
$
490
|
|
$
346
|
Adjusted EBITDA
margin
|
|
12.3 %
|
|
9.4 %
|
Non-GAAP diluted
EPS
|
|
$
2.29
|
|
$
1.47
|
|
|
|
|
|
* Non-GAAP financial
measures should be considered in addition to, but not as a
substitute for, the information provided in accordance with GAAP.
Management believes that these non-GAAP measures provide another
measure of Leidos' results of operations and financial condition,
including its ability to comply with financial covenants.
See Non-GAAP Financial Measures at the end of this press
release for more information and a reconciliation of our selected
reported results to these non-GAAP measures.
|
Revenues for the quarter were $3.98
billion, up 7% compared to the first quarter of 2023.
Revenues grew year-over-year due to increased demand across all
customer segments, especially for managed health services.
For the first quarter, net income was $283 million, or $2.07 per diluted share. Net income and diluted
EPS were up 73% and 77% year-over-year, respectively. Net income
margin of 7.1% increased from 4.4% in the first quarter of
2023.
Adjusted EBITDA was $490 million
for the first quarter, up 42% year-over-year. Record adjusted
EBITDA margin of 12.3% increased from 9.4% in the first quarter of
2023. Non-GAAP net income was $313
million for the first quarter, up 53% year-over-year, and
non-GAAP diluted EPS for the quarter was $2.29, up 56% year-over-year. The primary drivers
of increased profitability were increased volumes on fixed-rate
managed health services and improved cost control across the
company.
Cash Flow Summary
In the first quarter, Leidos generated $63 million of net cash provided by operating
activities and used $12 million in
investing activities and $228 million
in financing activities. Net cash provided by operating activities
was driven by strong EBITDA and collections performance. Days Sales
Outstanding (DSO) for the quarter was 62, in line with the first
quarter of 2023.
Investing activities consisted primarily of $17 million in property, equipment and software
payments, which resulted in quarterly free cash flow of
$46 million. Leidos returned
$236 million to shareholders in the
first quarter, including $183 million
in share repurchases and $53 million
as part of its regular quarterly cash dividend program. As of
March 29, 2024, Leidos had $633
million in cash and cash equivalents and $4.7 billion of debt.
On April 26, 2024, the Leidos Board of Directors declared a
cash dividend of $0.38 per share to
be paid on June 28, 2024, to stockholders of record at the
close of business on June 14, 2024.
Business Development
Net bookings totaled $3.7 billion
in the quarter, representing a book-to-bill ratio of 0.9. As a
result, backlog at the end of the quarter was $36.6 billion, of which $8.0 billion was funded.
Forward Guidance
Leidos is updating its fiscal year 2024 guidance as follows:
|
FY24
Guidance
|
Measure
|
Current
|
Prior
|
Revenues
(billions)
|
$16.0 -
$16.4
|
$15.7 -
$16.1
|
Adjusted EBITDA
Margin
|
Mid-to-High
11%
|
Mid-to-High
10%
|
Non-GAAP Diluted
EPS
|
$8.40 -
$8.80
|
$7.50 -
$7.90
|
Cash Flows Provided by
Operating Activities (billions)
|
approximately
$1.3
|
approximately
$1.1
|
For information regarding adjusted EBITDA margin and non-GAAP
diluted EPS, see the related explanations and reconciliations to
GAAP measures included elsewhere in this release.
Leidos does not provide a reconciliation of forward-looking
adjusted EBITDA margins or non-GAAP diluted EPS to net income due
to the inherent difficulty in forecasting and quantifying certain
amounts that are necessary for such reconciliation. Because certain
deductions for non-GAAP exclusions used to calculate projected net
income may vary significantly based on actual events, Leidos is not
able to forecast on a GAAP basis with reasonable certainty all
deductions needed in order to provide a GAAP calculation of
projected net income at this time. The amounts of these deductions
may be material and, therefore, could result in projected net
income and diluted EPS being materially less than what may be
implied by projected adjusted EBITDA margins and non-GAAP diluted
EPS.
Conference Call Information
Leidos management will discuss operations and financial results
in an earnings conference call beginning at 8 A.M. eastern time on April 30, 2024. A
live audio broadcast of the conference call along with a
supplemental presentation will be available to the public through
links on the Leidos Investor Relations website
(http://ir.leidos.com). An archived version of the webcast will be
available on the Leidos Investor Relations website until
April 30, 2025.
About Leidos
Leidos is a Fortune 500® innovation company rapidly
addressing the world's most vexing challenges in national security
and health. The company's global workforce of 47,000 collaborates
to create smarter technology solutions for customers in heavily
regulated industries. Headquartered in Reston, Virginia, Leidos reported annual
revenues of approximately $15.4 billion for the fiscal year ended
December 29, 2023. For more information, visit
www.leidos.com.
Forward-Looking Statements
Certain statements in this release contain or are based on
"forward-looking" information within the meaning of the Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify forward-looking statements by words such as "expects,"
"intends," "plans," "anticipates," "believes," "estimates,"
"guidance" and similar words or phrases. Forward-looking statements
in this release include, among others, estimates of our future
growth, strategy and financial and operating performance, including
future revenues, adjusted EBITDA margins, diluted EPS (including on
a non-GAAP basis) and cash flows provided by operating activities,
as well as statements about our business contingency plans,
government budgets and the ongoing Continuing Resolution,
uncertainties in tax due to new tax legislation or other regulatory
developments, strategy, planned investments, sustainability goals
and our future dividends, share repurchases, capital expenditures,
debt repayments, acquisitions, dispositions and cash flow
conversion. These statements reflect our belief and assumptions as
to future events that may not prove to be accurate.
Actual performance and results may differ materially from those
results anticipated by our guidance and other forward-looking
statements made in this release depending on a variety of factors,
including, but not limited to: developments in the U.S. government
defense and non-defense budgets, including budget reductions,
sequestration, implementation of spending limits or changes in
budgetary priorities, delays in the U.S. government budget process
or a government shutdown, or the U.S. government's failure to raise
the debt ceiling, which increases the possibility of a default by
the U.S. government on its debt obligations, related credit-rating
downgrades, or an economic recession; uncertainties in tax due to
new tax legislation or other regulatory developments; rising
inflationary pressures and fluctuations in interest rates; delays
in the U.S. government contract procurement process or the award of
contracts and delays or loss of contracts as a result of competitor
protests; changes in U.S. government procurement rules, regulations
and practices; our compliance with various U.S. government and
other government procurement rules and regulations; governmental
reviews, audits and investigations of our company; our ability to
effectively compete and win contracts with the U.S. government and
other customers; our ability to respond rapidly to emerging
technology trends, including the use of artificial intelligence;
our reliance on information technology spending by
hospitals/healthcare organizations; our reliance on infrastructure
investments by industrial and natural resources organizations;
energy efficiency and alternative energy sourcing investments;
investments by U.S. government and commercial organizations in
environmental impact and remediation projects; the effects of
health epidemics, pandemics and similar outbreaks may have on our
business, financial position, results of operations and/or cash
flows; our ability to attract, train and retain skilled employees,
including our management team, and to obtain security clearances
for our employees; our ability to accurately estimate costs,
including cost increases due to inflation, associated with our
firm-fixed-price contracts and other contracts; resolution of legal
and other disputes with our customers and others or legal or
regulatory compliance issues; cybersecurity, data security or other
security threats, system failures or other disruptions of our
business; our compliance with international, federal, state and
local laws and regulations regarding privacy, data security,
protection, storage, retention, transfer and disposal, technology
protection and personal information; the damage and disruption to
our business resulting from natural disasters and the effects of
climate change; our ability to effectively acquire businesses and
make investments; our ability to maintain relationships with prime
contractors, subcontractors and joint venture partners; our ability
to manage performance and other risks related to customer
contracts; the failure of our inspection or detection systems to
detect threats; the adequacy of our insurance programs, customer
indemnifications or other liability protections designed to protect
us from significant product or other liability claims, including
cybersecurity attacks; our ability to manage risks associated with
our international business; our ability to comply with the U.S.
Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and
similar worldwide anti-corruption and anti-bribery laws and
regulations; our ability to protect our intellectual property and
other proprietary rights by third parties of infringement,
misappropriation or other violations by us of their intellectual
property rights; our ability to prevail in litigation brought by
third parties of infringement, misappropriation or other violations
by us of their intellectual property rights; our ability to declare
or increase future dividends based on our earnings, financial
condition, capital requirements and other factors, including
compliance with applicable law and our agreements; our ability to
grow our commercial health and infrastructure businesses, which
could be negatively affected by budgetary constraints faced by
hospitals and by developers of energy and infrastructure projects;
our ability to successfully integrate acquired businesses; and our
ability to execute our business plan and long-term management
initiatives effectively and to overcome these and other known and
unknown risks that we face.
These are only some of the factors that may affect the
forward-looking statements contained in this release. For further
information concerning risks and uncertainties associated with our
business, please refer to the filings we make from time to time
with the U.S. Securities and Exchange Commission ("SEC"), including
the "Risk Factors," "Management's Discussion and Analysis of
Financial Condition and Results of Operations" and "Legal
Proceedings" sections of our latest Annual Report on Form 10-K and
Quarterly Reports on Form 10-Q, all of which may be viewed or
obtained through the Investor Relations section of our website at
www.leidos.com.
All information in this release is as of April 30, 2024.
Leidos expressly disclaims any duty to update the guidance or any
other forward-looking statement provided in this release to reflect
subsequent events, actual results or changes in Leidos'
expectations. Leidos also disclaims any duty to comment upon or
correct information that may be contained in reports published by
investment analysts or others.
CONTACTS:
|
|
|
|
|
|
Investor
Relations:
|
|
Media
Relations:
|
Stuart Davis
|
|
Melissa Lee
Dueñas
|
571.526.6124
|
|
571.526.6850
|
ir@leidos.com
|
|
Duenasml@leidos.com
|
LEIDOS HOLDINGS,
INC.
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except
per share data)
|
|
|
|
Three Months
Ended
|
|
|
March 29,
2024
|
|
March 31,
2023
|
Revenues
|
|
$
3,975
|
|
$
3,699
|
Cost of
revenues
|
|
3,337
|
|
3,204
|
Selling, general and
administrative expenses
|
|
226
|
|
233
|
Acquisition,
integration and restructuring costs
|
|
4
|
|
3
|
Equity earnings of
non-consolidated subsidiaries
|
|
(7)
|
|
(6)
|
Operating
income
|
|
415
|
|
265
|
Non-operating income
(expense):
|
|
|
|
|
Interest expense,
net
|
|
(49)
|
|
(54)
|
Other income
(expense), net
|
|
2
|
|
(4)
|
Income before income
taxes
|
|
368
|
|
207
|
Income tax
expense
|
|
(85)
|
|
(43)
|
Net income
|
|
283
|
|
164
|
Less: net (loss) income
attributable to non-controlling interest
|
|
(1)
|
|
2
|
Net income attributable
to Leidos common stockholders
|
|
$
284
|
|
$
162
|
|
|
|
|
|
Earnings per
share:
|
|
|
|
|
Basic
|
|
$
2.09
|
|
$
1.18
|
Diluted
|
|
2.07
|
|
1.17
|
|
|
|
|
|
Weighted average number
of common shares outstanding:
|
|
|
|
|
Basic
|
|
136
|
|
137
|
Diluted
|
|
137
|
|
138
|
|
|
|
|
|
Cash dividends declared
per share
|
|
$
0.38
|
|
$
0.36
|
LEIDOS HOLDINGS,
INC.
UNAUDITED CONDENSED
CONSOLIDATED BALANCE SHEETS
(in millions, except
share and per share data)
|
|
|
|
March 29,
2024
|
|
December 29,
2023
|
Assets:
|
|
|
|
|
Cash and cash
equivalents
|
|
$
633
|
|
$
777
|
Receivables,
net
|
|
2,713
|
|
2,429
|
Inventory,
net
|
|
318
|
|
310
|
Other current
assets
|
|
486
|
|
489
|
Total current
assets
|
|
4,150
|
|
4,005
|
Property, plant and
equipment, net
|
|
972
|
|
961
|
Intangible assets,
net
|
|
629
|
|
667
|
Goodwill
|
|
6,099
|
|
6,112
|
Operating lease
right-of-use assets, net
|
|
493
|
|
512
|
Other long-term
assets
|
|
474
|
|
438
|
Total assets
|
|
$
12,817
|
|
$ 12,695
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
Accounts payable and
accrued liabilities
|
|
$
2,301
|
|
$
2,277
|
Accrued payroll and
employee benefits
|
|
740
|
|
695
|
Current portion of
long-term debt
|
|
43
|
|
18
|
Total current
liabilities
|
|
3,084
|
|
2,990
|
Long-term debt, net of
current portion
|
|
4,636
|
|
4,664
|
Operating lease
liabilities
|
|
495
|
|
516
|
Other long-term
liabilities
|
|
289
|
|
267
|
Total
liabilities
|
|
8,504
|
|
8,437
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
Common stock, $0.0001
par value, 500,000,000 shares authorized, 135,097,654
and
135,766,419 shares
issued and outstanding at March 29, 2024, and December
29,
2023,
respectively
|
|
—
|
|
—
|
Additional paid-in
capital
|
|
1,735
|
|
1,885
|
Retained
earnings
|
|
2,595
|
|
2,364
|
Accumulated other
comprehensive loss
|
|
(72)
|
|
(48)
|
Total Leidos
stockholders' equity
|
|
4,258
|
|
4,201
|
Non-controlling
interest
|
|
55
|
|
57
|
Total stockholders'
equity
|
|
4,313
|
|
4,258
|
Total liabilities and
stockholders' equity
|
|
$
12,817
|
|
$ 12,695
|
LEIDOS HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH
FLOWS
(in millions)
|
|
|
|
Three Months
Ended
|
|
|
March 29,
2024
|
|
March 31,
2023
|
Cash flows from
operations:
|
|
|
|
|
Net income
|
|
$
283
|
|
$
164
|
Adjustments to
reconcile net income to net cash provided by (used in)
operations:
|
|
|
|
|
Depreciation and
amortization
|
|
69
|
|
82
|
Stock-based
compensation
|
|
20
|
|
18
|
Deferred income
taxes
|
|
(25)
|
|
(43)
|
Other
|
|
(6)
|
|
5
|
Change in assets and
liabilities:
|
|
|
|
|
Receivables
|
|
(281)
|
|
(166)
|
Other current assets
and other long-term assets
|
|
(35)
|
|
(9)
|
Accounts payable and
accrued liabilities and other long-term liabilities
|
|
(101)
|
|
(97)
|
Accrued payroll and
employee benefits
|
|
48
|
|
13
|
Income taxes
receivable/payable
|
|
91
|
|
(65)
|
Net cash provided by
(used in) operating activities
|
|
63
|
|
(98)
|
Cash flows from
investing activities:
|
|
|
|
|
Payments for property,
equipment and software
|
|
(17)
|
|
(39)
|
Other
|
|
5
|
|
—
|
Net cash used in
investing activities
|
|
(12)
|
|
(39)
|
Cash flows from
financing activities:
|
|
|
|
|
Proceeds from debt
issuance
|
|
—
|
|
1,743
|
Repayments of
borrowings
|
|
(4)
|
|
(1,711)
|
Payments for debt
issuance costs
|
|
—
|
|
(7)
|
Dividend
payments
|
|
(53)
|
|
(50)
|
Repurchases of stock
and other
|
|
(183)
|
|
(43)
|
Proceeds from issuances
of stock
|
|
13
|
|
12
|
Net capital
distributions to non-controlling interests
|
|
(1)
|
|
(1)
|
Net cash used in
financing activities
|
|
(228)
|
|
(57)
|
Effect of foreign
exchange rate changes on cash, cash equivalents and restricted
cash
|
|
(4)
|
|
2
|
Net decrease in cash,
cash equivalents and restricted cash
|
|
(181)
|
|
(192)
|
Cash, cash equivalents
and restricted cash at beginning of period
|
|
928
|
|
683
|
Cash, cash equivalents
and restricted cash at end of period
|
|
747
|
|
491
|
Less: restricted cash
at end of period
|
|
114
|
|
112
|
Cash and cash
equivalents at end of period
|
|
$
633
|
|
$
379
|
LEIDOS HOLDINGS, INC.
UNAUDITED SEGMENT OPERATING
RESULTS
(in millions)
|
|
|
|
Three Months
Ended
|
|
|
March 29,
2024
|
|
March 31,
2023
|
Revenues:
|
|
|
|
|
National Security and
Digital
|
|
$ 1,793
|
|
$ 1,757
|
Health &
Civil
|
|
1,199
|
|
1,008
|
Commercial &
International
|
|
509
|
|
489
|
Defense
Systems
|
|
474
|
|
445
|
Total
|
|
$ 3,975
|
|
$ 3,699
|
|
|
|
|
|
Operating income
(loss):
|
|
|
|
|
National Security and
Digital
|
|
$
175
|
|
$
145
|
Health &
Civil
|
|
222
|
|
113
|
Commercial &
International
|
|
34
|
|
13
|
Defense
Systems
|
|
21
|
|
23
|
Corporate
|
|
(37)
|
|
(29)
|
Total
|
|
$
415
|
|
$
265
|
|
|
|
|
|
Operating income
margin:
|
|
|
|
|
National Security and
Digital
|
|
9.8 %
|
|
8.3 %
|
Health &
Civil
|
|
18.5 %
|
|
11.2 %
|
Commercial &
International
|
|
6.7 %
|
|
2.7 %
|
Defense
Systems
|
|
4.4 %
|
|
5.2 %
|
Total
|
|
10.4 %
|
|
7.2 %
|
National Security and Digital
National Security and Digital revenues of $1.79 billion increased by 2% compared to the
prior year quarter. Revenue growth was primarily driven by
increased volumes on the Sentinel contract and Defense Enclave
Services (DES) program. For the quarter, operating income margin
increased to 9.8% from 8.3% in the prior year quarter, and non-GAAP
operating income margin increased to 10.1% from 8.9% in the prior
year quarter. The increase in segment profitability was primarily
attributable to staffing efficiencies and milestone achievement on
certain fixed price programs.
Health & Civil
Health & Civil revenues of $1.20
billion increased by 19% compared to the prior year quarter.
Health & Civil operating income margin for the quarter was
18.5%, compared to 11.2% in the prior year quarter, and non-GAAP
operating income margin was 19.0%, compared to 12.2% in the prior
year quarter. The increase in revenues and segment profitability
was driven by increased volumes and case complexity within
the managed health services business.
Commercial & International
Commercial & International revenues of $509 million increased by 4% compared to the
prior year quarter driven by increased deliveries of security
products. Operating income margin for the quarter was 6.7%,
compared to 2.7% in the prior year quarter, and non-GAAP operating
margin was 8.3%, compared to 4.7% in the prior year quarter. The
increase in segment profitability was due to increased volumes and
improved cost control within the security products business.
Defense Systems
Defense Systems revenues of $474 million increased by 7%
compared to the prior year quarter, primarily driven by increased
volumes within the airborne surveillance and reconnaissance and
hypersonics businesses. Defense Systems operating income margin for
the quarter was 4.4%, compared to 5.2% in the prior year quarter,
and non-GAAP operating margin was 8.0%, compared to 9.7% in the
prior year quarter. The decrease in segment profitability is
primarily attributable to program mix shifts.
LEIDOS HOLDINGS, INC.
UNAUDITED
BACKLOG BY REPORTABLE SEGMENT
(in millions)
Backlog represents the estimated amount of future revenues to be
recognized under negotiated contracts. Backlog value is based on
management's estimates about volume of services, availability of
customer funding and other factors, and excludes contracts that are
under protest. Estimated backlog comprises both funded and
negotiated unfunded backlog. Backlog estimates are subject to
change and may be affected by several factors, including
modifications of contracts, non-exercise of options and foreign
currency movements.
Funded backlog for contracts with the U.S. government represents
the value on contracts for which funding is appropriated less
revenues previously recognized on these contracts. Funded backlog
for contracts with non-U.S. government entities and commercial
customers represents the estimated value on contracts, which may
cover multiple future years, under which Leidos is obligated to
perform, less revenue previously recognized on the contracts.
Negotiated unfunded backlog represents estimated amounts of
revenue to be earned in the future from contracts for which funding
has not been appropriated and unexercised priced contract options.
Negotiated unfunded backlog does not include unexercised option
periods and future potential task orders expected to be awarded
under IDIQ, General Services Administration Schedule or other
master agreement contract vehicles, with the exception of certain
IDIQ contracts where task orders are not competitively awarded or
separately priced but instead are used as a funding mechanism, and
where there is a basis for estimating future revenues and funding
on future anticipated task orders.
The estimated value of backlog as of the dates presented was as
follows:
|
|
March 29,
2024
|
|
March 31,
2023
|
Segment
|
|
Funded
|
|
Unfunded
|
|
Total
|
|
Funded
|
|
Unfunded
|
|
Total
|
National Security and
Digital
|
|
$
2,411
|
|
$
15,144
|
|
$
17,555
|
|
$
2,984
|
|
$ 13,030
|
|
$ 16,014
|
Health &
Civil
|
|
1,953
|
|
8,767
|
|
10,720
|
|
1,740
|
|
9,572
|
|
11,312
|
Commercial &
International
|
|
2,465
|
|
2,071
|
|
4,536
|
|
2,537
|
|
1,317
|
|
3,854
|
Defense
Systems
|
|
1,136
|
|
2,624
|
|
3,760
|
|
1,042
|
|
2,864
|
|
3,906
|
Total
|
|
$
7,965
|
|
$
28,606
|
|
$
36,571
|
|
$
8,303
|
|
$ 26,783
|
|
$ 35,086
|
LEIDOS HOLDINGS, INC.
UNAUDITED
NON-GAAP FINANCIAL MEASURES
Leidos uses and refers to organic revenue, non-GAAP operating
income, non-GAAP operating margin, adjusted EBITDA, adjusted EBITDA
margin, non-GAAP diluted EPS, non-GAAP free cash flow and non-GAAP
free cash flow conversion, which are not measures of financial
performance under generally accepted accounting principles in the
U.S. and, accordingly, these measures should not be considered in
isolation or as a substitute for the comparable GAAP measures and
should be read in conjunction with Leidos's consolidated financial
statements prepared in accordance with GAAP.
Management believes that these non-GAAP measures provide another
representation of the results of operations and financial
condition, including its ability to comply with financial
covenants. These non-GAAP measures are frequently used by financial
analysts covering Leidos and its peers. The computation of non-GAAP
measures may not be comparable to similarly titled measures
reported by other companies, thus limiting their use for
comparability.
Organic revenues capture the revenue that is inherent in
the underlying business excluding the impact of acquisitions and
divestitures made within the prior year; it is computed as current
revenues excluding revenues from acquisitions within the last 12
months and divestitures within the current and year-ago
periods.
Non-GAAP operating income is computed by excluding
the following discrete items from operating income:
- Acquisition, integration and restructuring costs – Represents
acquisition, integration, lease termination, severance costs and
retention costs related to acquisitions and restructuring
activities.
- Amortization of acquired intangible assets – Represents the
amortization of the fair value of the acquired intangible
assets.
Non-GAAP operating margin is computed by dividing
non-GAAP operating income by revenues.
Adjusted EBITDA is computed by excluding the following
items from income before income taxes: (i) discrete items as
identified above; (ii) interest expense; (iii) interest income;
(iv) depreciation expense; and (v) amortization of internally
developed intangible assets.
Adjusted EBITDA margin is computed by dividing
adjusted EBITDA by revenues.
Non-GAAP net income is computed by excluding the
discrete items listed under non-GAAP operating income and their
related tax impacts.
Non-GAAP diluted EPS is computed by dividing net
income attributable to Leidos common stockholders, adjusted for the
discrete items as identified above and the related tax impacts, by
the diluted weighted average number of common shares
outstanding.
Non-GAAP free cash flow is computed by deducting
expenditures for property, equipment and software from net cash
provided by (used in) operating activities.
Non-GAAP free cash flow conversion is computed by
dividing non-GAAP free cash flow by non-GAAP net income
attributable to Leidos common stockholders; operating cash flow
conversion is computed by dividing net cash provided by (used in)
operating activities by net income attributable to Leidos
shareholders.
LEIDOS HOLDINGS, INC.
UNAUDITED
NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions,
except growth percentages)
The following table presents the reconciliation of revenues to
organic revenues by reportable segment and total operations:
|
|
Three Months
Ended
|
|
|
|
|
March 29,
2024
|
|
March 31,
2023
|
|
Percent
Change
|
National Security
and Digital
|
|
|
|
|
|
|
Revenues, as
reported
|
|
$
1,793
|
|
$
1,757
|
|
2 %
|
|
|
|
|
|
|
|
Health &
Civil
|
|
|
|
|
|
|
Revenues, as
reported
|
|
$
1,199
|
|
$
1,008
|
|
19 %
|
|
|
|
|
|
|
|
Commercial &
International
|
|
|
|
|
|
|
Revenues, as
reported
|
|
$
509
|
|
$
489
|
|
4 %
|
|
|
|
|
|
|
|
Defense
Systems
|
|
|
|
|
|
|
Revenues, as
reported
|
|
$
474
|
|
$
445
|
|
7 %
|
Acquisition and
divestiture revenues(1)
|
|
—
|
|
2
|
|
|
Organic
revenues
|
|
$
474
|
|
$
443
|
|
7 %
|
|
|
|
|
|
|
|
Total
Operations
|
|
|
|
|
|
|
Revenues, as
reported
|
|
$
3,975
|
|
$
3,699
|
|
7 %
|
Acquisition and
divestiture revenues(1)
|
|
—
|
|
2
|
|
|
Organic
revenues
|
|
$
3,975
|
|
$
3,697
|
|
8 %
|
(1) Year ago
acquisition and divestiture revenues reflect revenues from assets
subsequently divested. For the three months ended March 31,
2023, Defense Systems segment acquisition and divestiture revenues
include the divestiture of an immaterial asset that was
completed on October 20, 2023.
|
LEIDOS HOLDINGS, INC.
UNAUDITED
NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions,
except per share data and margin percentages)
The following tables present the reconciliation of non-GAAP
operating income, net income, diluted EPS, adjusted EBITDA, and
adjusted EBITDA margin to the most directly comparable GAAP
measures for the three months ended March 29, 2024:
|
|
Three Months Ended
March 29, 2024
|
|
|
As
reported
|
|
Acquisition,
integration and
restructuring
costs
|
|
Amortization of
acquired
intangibles
|
|
Non-GAAP
results
|
Operating
income
|
|
$
415
|
|
$
4
|
|
$
37
|
|
$
456
|
Non-operating expense,
net
|
|
(47)
|
|
—
|
|
—
|
|
(47)
|
Income before income
taxes
|
|
368
|
|
4
|
|
37
|
|
409
|
Income tax
expense(1)
|
|
(85)
|
|
(1)
|
|
(10)
|
|
(96)
|
Net income
|
|
283
|
|
3
|
|
27
|
|
313
|
Less: net loss
attributable to non-controlling interest
|
|
(1)
|
|
—
|
|
—
|
|
(1)
|
Net income attributable
to Leidos common stockholders
|
|
$
284
|
|
$
3
|
|
$
27
|
|
$
314
|
|
|
|
|
|
|
|
|
|
Diluted EPS
attributable to Leidos common stockholders(2)
|
|
$
2.07
|
|
$
0.02
|
|
$
0.20
|
|
$
2.29
|
Diluted
shares
|
|
137
|
|
137
|
|
137
|
|
137
|
|
|
Three Months Ended
March 29, 2024
|
|
|
As
reported
|
|
Acquisition,
integration and
restructuring
costs
|
|
Amortization of
acquired
intangibles
|
|
Non-GAAP
results
|
Net income
|
|
$
283
|
|
$
3
|
|
$
27
|
|
$
313
|
Income tax
expense(1)
|
|
85
|
|
1
|
|
10
|
|
96
|
Income before income
taxes
|
|
368
|
|
4
|
|
37
|
|
409
|
Depreciation
expense
|
|
32
|
|
—
|
|
—
|
|
32
|
Amortization of
intangibles
|
|
37
|
|
—
|
|
(37)
|
|
—
|
Interest expense,
net
|
|
49
|
|
—
|
|
—
|
|
49
|
EBITDA
|
|
$
486
|
|
$
4
|
|
$
—
|
|
$
490
|
EBITDA
margin
|
|
12.2 %
|
|
|
|
|
|
12.3 %
|
(1) Calculation uses an
estimated statutory tax rate on non-GAAP adjustments.
|
(2) Earnings per share
is computed independently for each of the non-GAAP adjustment
presented and therefore may not sum to the total non-GAAP earnings
per share due to rounding.
|
LEIDOS HOLDINGS, INC.
UNAUDITED
NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions,
except per share data and margin percentages)
The following tables present the reconciliation of non-GAAP
operating income, net income, diluted EPS, adjusted EBITDA, and
adjusted EBITDA margin to the most directly comparable GAAP
measures for the three months ended March 31, 2023:
|
|
Three Months Ended
March 31, 2023
|
|
|
As reported
|
|
Acquisition,
integration and
restructuring
costs
|
|
Amortization of
acquired
intangibles
|
|
Non-GAAP
results
|
Operating
income
|
|
$
265
|
|
$
3
|
|
$
52
|
|
$
320
|
Non-operating expense,
net
|
|
(58)
|
|
—
|
|
—
|
|
(58)
|
Income before income
taxes
|
|
207
|
|
3
|
|
52
|
|
262
|
Income tax
expense(1)
|
|
(43)
|
|
(1)
|
|
(13)
|
|
(57)
|
Net income
|
|
164
|
|
2
|
|
39
|
|
205
|
Less: net income
attributable to non-controlling interest
|
|
2
|
|
—
|
|
—
|
|
2
|
Net income attributable
to Leidos common stockholders
|
|
$
162
|
|
$
2
|
|
$
39
|
|
$
203
|
|
|
|
|
|
|
|
|
|
Diluted EPS
attributable to Leidos common stockholders(2)
|
|
$
1.17
|
|
$
0.01
|
|
$
0.28
|
|
$
1.47
|
Diluted
shares
|
|
138
|
|
138
|
|
138
|
|
138
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, 2023
|
|
|
As reported
|
|
Acquisition,
integration and
restructuring
costs
|
|
Amortization of
acquired
intangibles
|
|
Non-GAAP
results
|
Net income
|
|
$
164
|
|
$
2
|
|
$
39
|
|
$
205
|
Income tax
expense(1)
|
|
43
|
|
1
|
|
13
|
|
57
|
Income before income
taxes
|
|
207
|
|
3
|
|
52
|
|
262
|
Depreciation
expense
|
|
30
|
|
—
|
|
—
|
|
30
|
Amortization of
intangibles
|
|
52
|
|
—
|
|
(52)
|
|
—
|
Interest expense,
net
|
|
54
|
|
—
|
|
—
|
|
54
|
EBITDA
|
|
$
343
|
|
$
3
|
|
$
—
|
|
$
346
|
EBITDA
margin
|
|
9.3 %
|
|
|
|
|
|
9.4 %
|
(1) Calculation uses an
estimated statutory tax rate on non-GAAP adjustments.
|
(2) Earnings per share
is computed independently for each of the non-GAAP adjustment
presented and therefore may not sum to the total non-GAAP earnings
per share due to rounding.
|
LEIDOS HOLDINGS, INC.
UNAUDITED
NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions,
except margin percentages)
The following tables present the reconciliation of non-GAAP
operating income by reportable segment and Corporate to operating
income:
|
|
Three Months Ended
March 29, 2024
|
|
|
Operating income
(loss)
|
|
Acquisition,
integration and
restructuring
costs
|
|
Amortization of
acquired
intangibles
|
|
Non-GAAP
operating
income (loss)
|
|
Non-GAAP
operating
margin
|
National Security and
Digital
|
|
$
175
|
|
$
—
|
|
$
6
|
|
$
181
|
|
10.1 %
|
Health &
Civil
|
|
222
|
|
—
|
|
6
|
|
228
|
|
19.0 %
|
Commercial &
International
|
|
34
|
|
—
|
|
8
|
|
42
|
|
8.3 %
|
Defense
Systems
|
|
21
|
|
—
|
|
17
|
|
38
|
|
8.0 %
|
Corporate
|
|
(37)
|
|
4
|
|
—
|
|
(33)
|
|
NM
|
Total
|
|
$
415
|
|
$
4
|
|
$
37
|
|
$
456
|
|
11.5 %
|
|
|
|
Three Months Ended
March 31, 2023
|
|
|
Operating income
(loss)
|
|
Acquisition,
integration and
restructuring
costs
|
|
Amortization of
acquired
intangibles
|
|
Non-GAAP
operating
income (loss)
|
|
Non-GAAP
operating
margin
|
National Security and
Digital
|
|
$
145
|
|
$
—
|
|
$
12
|
|
$
157
|
|
8.9 %
|
Health &
Civil
|
|
113
|
|
—
|
|
10
|
|
123
|
|
12.2 %
|
Commercial &
International
|
|
13
|
|
—
|
|
10
|
|
23
|
|
4.7 %
|
Defense
Systems
|
|
23
|
|
—
|
|
20
|
|
43
|
|
9.7 %
|
Corporate
|
|
(29)
|
|
3
|
|
—
|
|
(26)
|
|
NM
|
Total
|
|
$
265
|
|
$
3
|
|
$
52
|
|
$
320
|
|
8.7 %
|
NM - Not
Meaningful
|
LEIDOS HOLDINGS, INC.
UNAUDITED
NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions,
except percentages)
The following table presents the reconciliation of non-GAAP free
cash flow to net cash provided by operating activities as well as
the calculation of operating cash flow and non-GAAP free cash flow
conversion ratios:
|
|
Three Months
Ended
|
|
|
March 29,
2024
|
|
March 31,
2023
|
Net cash provided by
(used in) operating activities
|
|
$
63
|
|
$
(98)
|
Payments for property,
equipment and software
|
|
(17)
|
|
(39)
|
Non-GAAP free cash
flow
|
|
$
46
|
|
$
(137)
|
|
|
|
|
|
Net income attributable
to Leidos common stockholders
|
|
$
284
|
|
$
162
|
Acquisition,
integration and restructuring costs(1)
|
|
3
|
|
2
|
Amortization of
acquired intangibles(1)
|
|
27
|
|
39
|
Non-GAAP net income
attributable to Leidos common stockholders
|
|
$
314
|
|
$
203
|
|
|
|
|
|
Operating cash flow
conversion ratio
|
|
22 %
|
|
(60) %
|
Non-GAAP free cash
flow conversion ratio
|
|
15 %
|
|
(67) %
|
(1) After-tax expenses
excluded from non-GAAP net income.
|
View original
content:https://www.prnewswire.com/news-releases/leidos-holdings-inc-reports-first-quarter-fiscal-year-2024-results-302130555.html
SOURCE Leidos